The Saudi Food & Drug Authority (“SFDA”) has issued V 7.0 of the Guideline on Requirements for Advertising and Promotion of Pharmaceutical and Herbal Products.

🔍 What’s new:

The guideline includes updates to the following areas:

• General Provisions

• Responsibilities of the Applicant

• Conditions and requirements for approval of consumer-directed advertising

• Special conditions for advertising via websites and social media platforms

• Contract requirements between establishments and social media influencers

• Submission mechanism

📅 Key Points:

• Advertising approval validity is one year, with the possibility of extension or renewal up to five years while retaining the same license number (consumer-directed advertising).
• For influencer advertising, SFDA must be notified at least 12 hours prior to publication, and a contract and valid Mawthooq license must be provided.
• The stated processing timeline is 15 working days, and the fee is SAR 14,000 per registered product per advertising format.

📌 How ReguLinked can support you:

ReguLinked supports companies by reviewing advertising materials against SFDA-approved PIL/SPC.
Supporting social media and influencer advertising requirements, and advising on license validity, renewal, and documentation retention in line with last updates.

Book your complimentary consultation today

📧 bd@regulinked.com | 🌐 www.regulinked.com

📎 Official Guideline: Advertising and Promotion of Pharmaceutical and Herbal Products

#ReguLinked #SFDA #PharmaceuticalAdvertising #HerbalProducts #AdvertisingCompliance #RegulatoryUpdate #Pharma #KSA #GCC #MarketAccess #RegulatoryAffairs